115 related articles for article (PubMed ID: 11091181)
1. Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy.
Booth S; Curley HM; Varnai C; Arnold R; Lee LYW; Campton NA; Cook G; Purshouse K; Aries J; Innes A; Cook LB; Tomkins O; Oram HS; Tilby M; Kulasekararaj A; Wrench D; Dolly S; Newsom-Davies T; Pettengell R; Gault A; Moody S; Mittal S; Altohami M; Tillet T; Illingworth J; Mukherjee L; Apperly J; Ashcroft J; Rabin N; Carmichael J; Cazier JB; Kerr R; Middleton G; Collins GP; Palles C;
Br J Haematol; 2022 Feb; 196(4):892-901. PubMed ID: 34761389
[TBL] [Abstract][Full Text] [Related]
2. A Scoping Review of Otologic Manifestations of Hematologic Malignancies.
Raymond MJ; Ottinger A; Rowley MA; Bobian M; Dornhoffer J; Brennan E; Rizk HG
Otol Neurotol; 2024 Apr; 45(4):362-375. PubMed ID: 38437804
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy Delays Due to SARS-CoV-2 Infection in Children With Leukemia or Lymphoma.
Ruiz J; Aldewereld Z; Elgarten C
JAMA Netw Open; 2024 Feb; 7(2):e2355679. PubMed ID: 38363574
[No Abstract] [Full Text] [Related]
4. Telomerase inhibition in haematological neoplasms-are we ready for primetime?
Patnaik MM
Lancet; 2024 Jan; 403(10423):220-222. PubMed ID: 38048790
[No Abstract] [Full Text] [Related]
5. Angiogenesis and Minimal Residual Disease in Patients with Acute Myeloid Leukemia.
Nematollahi P; Baradaran A; Kasaei Koopaei Z; Sajjadieh H
Int J Hematol Oncol Stem Cell Res; 2020 Apr; 14(2):93-98. PubMed ID: 32461792
[No Abstract] [Full Text] [Related]
6. Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study.
Ma X; Li L; Zhang L; Fu X; Li X; Wang X; Wu J; Sun Z; Zhang X; Feng X; Chang Y; Zhou Z; Nan F; Zhang J; Li Z; Zhang M
Drug Des Devel Ther; 2020; 14():275-284. PubMed ID: 32158186
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17.
Basta D; Latinovic O; Lafferty MK; Sun L; Bryant J; Lu W; Caccuri F; Caruso A; Gallo R; Garzino-Demo A
Pathog Dis; 2015 Nov; 73(8):ftv062. PubMed ID: 26333571
[TBL] [Abstract][Full Text] [Related]
8. Levels of bone marrow microvessel density are crucial for evaluating the status of acute myeloid leukemia.
Song Y; Tan Y; Liu L; Wang Q; Zhu J; Liu M
Oncol Lett; 2015 Jul; 10(1):211-215. PubMed ID: 26171001
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of magnetic resonance imaging as a prognostic variable in myelodysplastic syndromes.
Ziółko E; Kwiatkowska-Pamuła A; Adamczyk T; Walecki J; Muc-Wierzgoń M
Med Sci Monit; 2014 Sep; 20():1634-40. PubMed ID: 25217620
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of serum proangiogenic molecules in patients with de novo non-Hodgkin lymphomas.
Rujirojindakul P; Lekhakula A
ScientificWorldJournal; 2012; 2012():215231. PubMed ID: 22629121
[TBL] [Abstract][Full Text] [Related]
11. Tumor angiogenesis as a target for dietary cancer prevention.
Li WW; Li VW; Hutnik M; Chiou AS
J Oncol; 2012; 2012():879623. PubMed ID: 21977033
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model.
Van Valckenborgh E; Croucher PI; De Raeve H; Carron C; De Leenheer E; Blacher S; Devy L; Noël A; De Bruyne E; Asosingh K; Van Riet I; Van Camp B; Vanderkerken K
Am J Pathol; 2004 Sep; 165(3):869-78. PubMed ID: 15331411
[TBL] [Abstract][Full Text] [Related]
13. Increased angiogenesis in cutaneous T-cell lymphomas.
Mazur G; Woźniak Z; Wróbel T; Maj J; Kuliczkowski K
Pathol Oncol Res; 2004; 10(1):34-6. PubMed ID: 15029259
[TBL] [Abstract][Full Text] [Related]
14. [Therapy-related changes of angiogenesis in Philadelphia chromosome positive chronic myelogenous leukemia].
Kvasnicka HM; Thiele J; Staib P; Engels K; Kriener S; Schmitt-Graeff A
Pathologe; 2004 Mar; 25(2):127-34. PubMed ID: 15010998
[TBL] [Abstract][Full Text] [Related]
15. Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma.
Pazgal I; Zimra Y; Tzabar C; Okon E; Rabizadeh E; Shaklai M; Bairey O
Br J Cancer; 2002 Jun; 86(11):1770-5. PubMed ID: 12087465
[TBL] [Abstract][Full Text] [Related]
16. Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo.
Van Valckenborgh E; De Raeve H; Devy L; Blacher S; Munaut C; Noël A; Van Marck E; Van Riet I; Van Camp B; Vanderkerken K
Br J Cancer; 2002 Mar; 86(5):796-802. PubMed ID: 11875745
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and angiogenic mediators in haematological malignancies.
Mangi MH; Newland AC
Br J Haematol; 2000 Oct; 111(1):43-51. PubMed ID: 11091181
[No Abstract] [Full Text] [Related]
18. The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignancies.
Giles FJ
Oncologist; 2001; 6 Suppl 5():32-9. PubMed ID: 11700390
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects.
Sledge GW
Semin Oncol; 2002 Jun; 29(3 Suppl 11):104-10. PubMed ID: 12138404
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
